“…In contrast, in a small study, La Marca et al (2004b) observed a positive correlation between serum AMH levels and the HOMA index, an insulin resistance index calculated from fasting insulin and fasting glucose levels. Improvement of insulin levels by insulin-lowering drugs, such as metformin and thiazolidinediones, which also indirectly affect androgen production, have been shown to be beneficial in PCOS women (Franks et al 1999). In a study of obese PCOS women, metformin treatment suppressed androstenedione levels and ovulation rate (Fleming et al 2005), although androgen levels were still above the upper limit of the normal range.…”